Sitomni-M 50/500

Sitomni-M 50/500 by EMK Omni Pharma is a prescription medicine containing Sitagliptin 50 mg and Metformin Hydrochloride 500 mg in film coated tablet form. This combination may be prescribed by healthcare professionals for physician-guided diabetes management support, particularly in patients who require a doctor-supervised approach to blood sugar control. Sitomni-M 50/500 Tablets by EMK Omni Pharma belong to the anti-diabetic pharmaceutical category and should be used only under medical supervision. The medicine contains Sitagliptin Phosphate equivalent to Sitagliptin and Metformin Hydrochloride, both widely used in prescription-based diabetes care. Patients should take this medicine only as advised by a registered medical practitioner and should not self-medicate or alter the dosage without professional guidance.

Sitomni-M 50/500 by EMK Omni Pharma may be prescribed by doctors as part of a physician-guided diabetes management plan for patients who require a combination of Sitagliptin and Metformin Hydrochloride. In clinical practice, this type of prescription medicine may be considered when a healthcare professional decides that combination anti-diabetic therapy is suitable for the patient’s condition, medical history and ongoing blood sugar management needs. Patients should use Sitomni-M 50/500 Tablets only under the supervision of a registered medical practitioner. They should not self-medicate, change the prescribed dosage, stop the medicine suddenly, combine it with other diabetes medicines, or use it with other prescriptions without consulting their doctor. Tablets should be taken only as advised by the physician and should not be crushed or chewed unless specifically instructed by a healthcare professional.